In this large prospective study, circulating IGF1 was inversely and independently associated with all-cause mortality in invasive breast cancer patients, and this association was consistent among patients with different strata of insulin and clinical characteristics. This evidence concerns the gene IGF1 and invasive breast carcinoma.